Charles M. Winter - Net Worth and Insider Trading

Charles M. Winter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Charles M. Winter owns 1 companies in total, including Janux Therapeutics Inc (JANX) .

Click here to see the complete history of Charles M. Winter’s form 4 insider trades.

Insider Ownership Summary of Charles M. Winter

Ticker	Comapny	Transaction Date	Type of Owner
JANX	Janux Therapeutics Inc	2023-01-01	Chief Technical Officer

Charles M. Winter Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Charles M. Winter Ownership Network

Ownership Network List of Charles M. Winter

No Data

Ownership Network Relation of Charles M. Winter

Charles M. Winter Owned Company Details

What does Janux Therapeutics Inc do?

Who are the key executives at Janux Therapeutics Inc?

Charles M. Winter is the Chief Technical Officer of Janux Therapeutics Inc. Other key executives at Janux Therapeutics Inc include director & 10 percent owner Jay Lichter , 10 percent owner Avalon Ventures Xi, L.p. , and 10 percent owner & Acting Chief Financial Officer Tighe Reardon .

Janux Therapeutics Inc (JANX) Insider Trades Summary

Over the past 18 months, Charles M. Winter made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net purchase of 849,854 shares made by Tighe Reardon , a net purchase of 849,854 shares made by Avalon Ventures Xi, L.p. , and a net purchase of 849,854 shares made by Jay Lichter .

In summary, during the past 3 months, insiders sold 0 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net purchase of 3,044,570 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Janux Therapeutics Inc Insider Transactions

No Available Data

Charles M. Winter Mailing Address

Above is the net worth, insider trading, and ownership report for Charles M. Winter. You might contact Charles M. Winter via mailing address: C/o Janux Therapeutics, Inc., 10955 Vista Sorrento Parkway, Suite 200, San Diego Ca 92130.

Discussions on Charles M. Winter

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.